Core Scientific, Inc. (CORZ)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
QuarterlyIQ Insights · CORZ
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -35.6% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 26.8% |
Growth built into the price is above our model estimate.
The price assumes 62.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 69 industry peers
CORZ — capital allocation — Creation of a Direct Financial Obligation or an Obligation under an Off-Balan…
Dated 2026-08-27
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information in
Why it matters: If revenue growth drops, it shows a weaker position in a slowing sector.
Worry ifCore Scientific's revenue growth falls below the sector median growth rate.
Less concerning ifCore Scientific maintains or improves its revenue growth above the median.
Why it matters: Finishing the expansion will add more power. This will help increase revenue.
Supportive ifThe Muskogee campus expansion is complete. It now has a power capacity of 1.5 GW.
Worry ifDelays in the expansion timeline or failure to meet the 1.5 GW target.
Why it matters: Completing this acquisition will boost Core Scientific's power capacity. It is important for growth.
Supportive ifAcquisition of Polaris DS LLC is completed by Q3 2026.
Worry ifThe acquisition is delayed or fails to close as planned.
Why it matters: Trends in net loss can indicate the company's operational efficiency and financial health. A decrease in losses is a positive sign.
Supportive ifNet loss in Q3 decreases by more than 20% compared to Q2 2026.
Worry ifNet loss in Q3 increases or remains flat compared to Q2 2026.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$310 on $10,000 · ±3.1% | How much price usually moves either way. |
| Bad day | $775 loss on $10,000 · 7.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,489 loss on $10,000 · 44.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The new credit facilities can improve capital efficiency and support growth plans. This is key for Core Scientific's expansion.
Supportive ifCore Scientific will soon report a big increase in capacity or project funding.
Worry ifThe company does not use the credit facilities well. There is no increase in capacity.
Why it matters: Updates on the expansion will show Core Scientific's ability to grow. This helps meet customer needs.
Watch forThe Muskogee campus expansion is done early.
Also watch forThe Muskogee campus expansion is delayed.
Why it matters: The expansion to 1.5 GW of gross power is crucial for scaling operations. It shows Core Scientific's growth trajectory.
Supportive ifCore Scientific announces the completion of the next 82 MW at Muskogee as planned in the second half of 2027.
Worry ifThere are delays in the Muskogee campus expansion. This shows problems in scaling operations.
Why it matters: Improving efficiency can help Core Scientific reduce costs and improve margins. This is vital for recovery.
Supportive ifManagement says operational costs fell by at least 10% from last quarter.
Worry ifOperational costs go up or stay the same from last quarter.
Why it matters: This offering is key for Core Scientific's money management and debt control.
Supportive ifCore Scientific finishes the debt offering and uses the money to lower debt.
Worry ifCore Scientific does not finish the offering or uses the money for losses.
Why it matters: Good debt management is key for Core Scientific's financial health and future growth.
Watch forManagement reports a reduction in total debt by at least 10% in the next quarter.
Also watch forTotal debt remains unchanged or increases in the next quarter.
Why it matters: The focus on debt management is key for Core Scientific's financial health. Progress here can boost confidence.
Supportive ifManagement says they will cut total debt by at least $500 million.
Worry ifManagement reports an increase in total debt or no progress in debt reduction.
Why it matters: Steady revenue growth in this area is important for Core Scientific's success.
Supportive ifHigh-density colocation revenue grows year over year by more than 20%.
Worry ifIf colocation revenue drops or grows less than 10% each year, it is a concern.
Why it matters: Deals can greatly boost Core Scientific's power and growth.
Supportive ifCore Scientific announces a new acquisition that adds at least 100 MW of power.
Worry ifNo new deals are announced, or they do not add enough power.